The team came together in 2016 to explore the possibility of developing a novel treatment approach to prevent or slow down some critical ophthalmologic disorders related to aging mostly. Scientific curiosity has led us to design clinical studies in vitro and in vivo to explore and clarify a novel treatment approach which has never been used in the field of ophthalmology before.
Iskender Alkin Solmaz
MD - CMO
●Graduated from Medical School in 2003 and completed his residency in ophthalmology in 2009.
●Currently working as an oculoplastic surgeon.
Inventor of the TelomeEYE treatment approach for this unique formulation
●Designed and conducted studies to prove the treatment concept.
MD - CSO
●Graduated from Medical School in 2005 and completed her residency in ophthalmology in 2011.
●Currently working as an anterior segment surgeon in her private clinic.
●Responsible for scientific research in TelomEYE Project.
●Designed and ran the preclinical and clinical studies.
●Experience in pharmaceutical and anti-aging businesses since 1995.
●Currently running several healthcare companies.
●Invested in and supported the early steps of the TelomEYE project.
●Running the business development part of the TelomEYE project.